Clinical trial
Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke -A Prospective, Multicenter, Randomized, Double-blind, Active-controlled Trial
NCT07369999 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke -A Prospective, Multicenter, Randomized, Double-blind, Active-controlled Trial
- Lead sponsor
- Xiangya Hospital of Central South University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 1, 2026
- Completion date
- June 30, 2029
- Enrollment
- 1,062 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
mild disabling acute ischemic stroke